Welcome to the editorial homepage for World Pharmaceuticals Frontiers. Here you can access directly all the features from the latest issue, as well as a handy glossary.
To ensure you receive your copy of World Pharmaceuticals Frontier, subscribe here.
BREAKING CHINA
China is a major challenge for the international pharmaceutical industry in many ways. Not only is
this a huge new market for modern drugs, it is also a major centre of counterfeiting and fake products.
Nevertheless, most international drug companies producing in China are learning to work in a demanding regulatory and commercial environment, Dr Engelbert Günster, Boehringer Ingelheim, tells Nigel Ash. more...
PAT TAKES SHAPE
Since 2002, the pharma industry and regulating authorities have been working together to improve the limitations of cGMPs in manufacturing with process analytical technology.
Robert P Cogdill, Duquesne University Center for Pharmaceutical Technology, examines the progress made. more...
BATTLE FOR SURVIVAL
During the last 20 years, huge investments have been made in the pharmaceutical manufacturing industry.
However, over last year a number of companies announced significant cuts in staff and plant closures. Maurice Parlane, director of New Wayz Consulting, has sound advice for companies intending to survive the next 20 years. more...
Drug Discovery & Development
Chemicals & Raw Materials
Drug Delivery
LOOK BEFORE YOU LEAP
RNAi was discovered less than a decade ago and it has already
proved to be a powerful genetic tool with the potential for treating
a wide range of diseases. Daniel H Kim and John J Rossi discuss the potential problem areas, solutions and applications that must be overcome before it becomes a real therapeutic modality. more...
SHAKE RATTLE AND ROLL
Master files list information about the content of a medicinal product, providing brand protection and a regulatory system for product quality and control.
Excipient manufacturers claim the
European Master Files system is out of sync with the regulatory environment, and is holding back the development of innovative new pharmaceutical products. Phil Taylor investigates. more...
BREACHING THE SKIN
Andrey A Gurtovenko and Jamshed Anwar of Computational Biophysics Laboratory, Institute of Pharmaceutical Innovation, University of Bradford, UK, discuss the molecular secrets of membrane barrier modulators in transdermal drug delivery. more...
IT & Data Management
Packaging
Regional Focus
COLLABORATE TO ACCUMULATE
Globalisation, mergers and acquisitions, expiring patents, and expanding markets are just some of the factors transforming the way that the pharmaceutical industry operates. These shifting dynamics bring opportunities for companies to collaborate and raise productivity on an international basis, writes Rudiger Dorn, managing director for Microsoft’s Worldwide Life Sciences Industry Group.more...
TIME TO GET TOUGH
trade in counterfeit drugs is reaching astronomical figures. nic Paton investigates the security measures available and how a unilateral effort from governments, regulators and the pharmaceutical industry is necessary if there is any hope of curtailing this illegal trade. more...
SCANDINAVIA TIME TO INVEST?
Scandinavia is ranked as one of the most innovative regions in the European pharmaceutical sector.
Christer Hedman, Business Region Göteborg, takes an in-depth look at the changes the industry has
undergone recently and reveals why Scandinavia is an attractive proposition for investors. more...
Supply Chain Management
Industry In Figures
Clinical Trials
CRIMINAL INTENTIONS
Counterfeit drugs are not just hitting pharmaceutical company profits, they are also costing lives. For producers, the shape of the challenge is clear but the scale is not. Andrew Jackson, deputy global head of corporate security at Novartis, tells Nigel Ash that real change can only come from the political landscape. more...
MARKET DIVERGENCE SOFTENS GROWTH The pharmaceutical industry is undergoing a period of transition. While growth is expected to slow for the mature sectors, the next 12 months will see stronger performances from emerging markets, writes Eva Edery, senior principal, global pharma strategy, IMS Health, EMEA. more...
LATIN FEVER
Latin America is shaping up to become a sound region for investment, with benefits for pharma beyond outsourcing their phase II and phase III clinical trials.
World Pharmaceutical Frontiers talks to Ernest Egli, Roche Brazil and Latin America, Mahabir P Gupta, University of Panama, and Manuel Fresno, iCON, about what Latin America holds for the future. more...
Published by Global Trade Media, a trading division of Cornhill Publications Limited
Registered Address: John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK
Registered in England No. 01564127
Tel: +44 207 936 6661 | Fax: +44 207 411 9800 | Email: info@globaltrademedia.com
